Valuation: Apex Biotechnology Corp.

Market Cap 3.2B 99.04M 85.67M 80M 73.39M 138M 9.43B 140M 939M 368M 4.72B 372M 364M 15.62B P/E 2024
23.7x
P/E 2025 18.8x
Enterprise Value 2.66B 82.48M 71.35M 66.63M 61.12M 115M 7.85B 117M 782M 307M 3.93B 310M 303M 13.01B EV / Sales 2024
1.37x
EV / Sales 2025 1.29x
Free-Float
58.42%
Yield 2024
3.99%
Yield 2025 4.27%
1 day+0.47%
1 week+2.24%
Current month+2.24%
1 month+5.61%
3 months+12.87%
6 months+5.26%
Current year+5.09%
1 week 31.75
Extreme 31.75
32.6
1 month 30.3
Extreme 30.3
33.1
Current year 28
Extreme 28
33.1
1 year 28
Extreme 28
38.7
3 years 25.6
Extreme 25.6
44.45
5 years 22.45
Extreme 22.45
44.45
10 years 17.3
Extreme 17.3
45.75
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2011-01-17
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 2011-01-17
Director/Board Member - 2011-01-17
Director/Board Member - 2018-05-24
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%+2.24%+7.38%+20.98% 99.04M
+0.30%+0.71%+35.82%+30.96% 12.79B
+0.23%-0.67%+19.86%+22.83% 6.81B
+5.64%+9.50%+58.61%+38.76% 6.21B
+0.69%+3.51% - - 5.5B
-0.58%-8.31%-27.67%+35.85% 4.36B
+1.30%-2.64%-22.46%-18.78% 4.04B
+4.06%+10.31%+55.05%-44.95% 1.91B
-0.51%-3.95%-16.71%+192.08% 1.75B
+0.92%+6.50%+57.45%-10.15% 1.71B
Average +1.25%+1.46%+18.59%+29.73% 4.52B
Weighted average by Cap. +1.22%+1.39%+23.19%+27.92%

Financials

2024 2025
Net sales 1.85B 57.35M 49.61M 46.33M 42.5M 79.94M 5.46B 81.21M 544M 213M 2.74B 215M 211M 9.04B 1.94B 60.23M 52.09M 48.65M 44.63M 83.94M 5.73B 85.27M 571M 224M 2.87B 226M 221M 9.5B
Net income 128M 3.96M 3.43M 3.2M 2.94M 5.52M 377M 5.61M 37.56M 14.74M 189M 14.88M 14.56M 625M 163M 5.04M 4.36M 4.07M 3.74M 7.03M 480M 7.14M 47.8M 18.76M 241M 18.94M 18.53M 795M
Net Debt -476M -14.73M -12.75M -11.9M -10.92M -20.54M -1.4B -20.86M -140M -54.81M -703M -55.33M -54.12M -2.32B -535M -16.56M -14.32M -13.37M -12.27M -23.08M -1.58B -23.44M -157M -61.59M -790M -62.17M -60.81M -2.61B
Logo Apex Biotechnology Corp.
APEX BIOTECHNOLOGY CORP is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of testing strips, electrode testing strips and tester suites. The Company primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.
Employees
-
Date Price Change Volume
26-08-10 NT$30.85 -3.59% 440,547
26-08-07 NT$32.00 +0.47% 108,997
26-08-06 NT$31.85 0.00% 91,258
26-08-05 NT$31.85 -1.24% 171,917
26-08-04 NT$32.25 -0.46% 130,316

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1733 Stock